Kristin Padavic

Phase I Pharmacokinetic and Biologic Correlative Study of Mapatumumab, a Fully Human Monoclonal Antibody With Agonist Activity to Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Receptor-1

Anthony W. Tolcher, Monica Mita, Neal J. Meropol et al. · Journal of Clinical Oncology · 2007 · 311 citations · Full text

Medicine, Oncology, Pharmacology +17

Mapatumumab, an Antibody Targeting TRAIL-R1, in Combination With Paclitaxel and Carboplatin in Patients With Advanced Solid Malignancies: Results of a Phase I and Pharmacokinetic Study

Stephen Leong, Roger B. Cohen, Daniel L. Gustafson et al. · Journal of Clinical Oncology · 2009 · 120 citations · Full text

Medicine, Oncology, Pharmacology +17

Depletion of Glutathione in Normal and Malignant Human Cells In Vivo by Buthionine Sulfoximine: Clinical and Biochemical Results

Peter J. O’Dwyer, Thomas C. Hamilton, Robert C. Young et al. · JNCI Journal of the National Cancer Institute · 1992 · 100 citations

Medicine, Oncology, Pharmacology +12

Phase I trial of recombinant macrophage colony-stimulating factor and recombinant gamma-interferon: toxicity, monocytosis, and clinical effects.

Louis M. Weiner, W. Li, Michele Holmes et al. · PubMed · 1994 · 89 citations

Life Sciences, Immunology, Pharmacology +8

Phase II trial of tamoxifen in metastatic carcinoma of the prostate

John H. Glick, Alan J. Wein, Kristin Padavic et al. · Cancer · 1982 · 35 citations · Full text

Medicine, Oncology, Pharmacotherapy +17